Scientists test dual attack to stop ebola in its tracks
NCT ID NCT05202288
Summary
This study aims to find the best way to combine two tools against Ebola: a proven vaccine (Ervebo) and a fast-acting antibody treatment (Inmazeb). Researchers want to see if giving them together affects how well the vaccine works, and to determine the safest and most effective timing between the two shots. The trial will involve 132 healthy adult volunteers in Guinea.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EBOLA VIRUS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.